Now Live The website is now live at www.aiartpublishing.com, with creator invitations, curated releases, and exhibition ...

Researchers have identified a promising new weapon against triple-negative breast cancer, one of the most aggressive forms of ...

December, flu activity across the U.S. and Canada remains high. Although cases are trending downward in Canada as of Jan 9, the season has yet to peak in the U.S., according to data from the Centers ...

SHANGHAI and SAN FRANCISCO, Jan. 12, 2026 /PRNewswire/ -- Oricell Therapeutics Holdings Limited ("Oricell" or "the Company"), a global leader in innovative cancer immunotherapy, announced today the ...

DengiAll emerges as a promising single-dose solution offering balanced protection against all four dengue types.

Backers claim the tests can predict a child’s risk of autism using a strand of hair or a mother’s blood, but critics say they are not ready for the market. A lab test used to determine the presence of ...

KBIA's Rebecca Smith after receiving both her COVID-19 booster and flu shot in 2021. Flu season is underway, and while cases are still low in Missouri, medical professionals are watching a variant ...

Creative Commons (CC): This is a Creative Commons license. Attribution (BY): Credit must be given to the creator. Lateral flow assays (LFAs) are point-of-care devices that are known for their ...

The human enhancement debate questions how far we should go in creating superior humans or bionic life. Stimulus check update: Trump details timeline for $2,000 direct payments Trump attacks ABC ...

A new approach targets the B-cell pathway with bispecific antibodies, building on decades of research that establishes the role of B cells and self-reactive antibodies in lupus, systemic sclerosis, ...

Alector Therapeutics is shelving a GSK-partnered antibody after the asset failed to slow disease progression in patients with a variety of frontotemporal dementia (FTD). In the pivot away from ...